Standard
Harvard
Dean, NE, Gsell, P-S, Brookmeyer, R, Crawford, FW, Donnelly, CA, Ellenberg, SS, Fleming, TR, Halloran, EM, Horby, P
, Jaki, T, Krause, PR, Longini, IM, Mulangu, S, Muyembe-Tamfum, J-J, Nason, MC, Smith, PG, Wang, R, Henao-Restrepo, AM & De Gruttola, V 2020, '
Creating a framework for conducting randomized clinical trials during disease outbreaks',
New England Journal of Medicine, vol. 382, no. 14, pp. 1366-1369.
https://doi.org/10.1056/NEJMsb1905390APA
Dean, N. E., Gsell, P.-S., Brookmeyer, R., Crawford, F. W., Donnelly, C. A., Ellenberg, S. S., Fleming, T. R., Halloran, E. M., Horby, P.
, Jaki, T., Krause, P. R., Longini, I. M., Mulangu, S., Muyembe-Tamfum, J.-J., Nason, M. C., Smith, P. G., Wang, R., Henao-Restrepo, A. M., & De Gruttola, V. (2020).
Creating a framework for conducting randomized clinical trials during disease outbreaks.
New England Journal of Medicine,
382(14), 1366-1369.
https://doi.org/10.1056/NEJMsb1905390Vancouver
Author
Bibtex
@article{04bc541c165341cc8a8ac0a18a7182aa,
title = "Creating a framework for conducting randomized clinical trials during disease outbreaks",
abstract = "As in the ongoing Covid-19 pandemic, global outbreaks of infectious illnesses often develop quickly and resolve in unpredictable ways. In this report, strategies to develop high-quality evidence to guide the development of new therapies are proposed.",
author = "N.E. Dean and P.-S. Gsell and R. Brookmeyer and F.W. Crawford and C.A. Donnelly and S.S. Ellenberg and T.R. Fleming and E.M. Halloran and P. Horby and T. Jaki and P.R. Krause and I.M. Longini and S. Mulangu and J.-J. Muyembe-Tamfum and M.C. Nason and P.G. Smith and R. Wang and A.M. Henao-Restrepo and {De Gruttola}, V.",
year = "2020",
month = apr,
day = "2",
doi = "10.1056/NEJMsb1905390",
language = "English",
volume = "382",
pages = "1366--1369",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "14",
}
RIS
TY - JOUR
T1 - Creating a framework for conducting randomized clinical trials during disease outbreaks
AU - Dean, N.E.
AU - Gsell, P.-S.
AU - Brookmeyer, R.
AU - Crawford, F.W.
AU - Donnelly, C.A.
AU - Ellenberg, S.S.
AU - Fleming, T.R.
AU - Halloran, E.M.
AU - Horby, P.
AU - Jaki, T.
AU - Krause, P.R.
AU - Longini, I.M.
AU - Mulangu, S.
AU - Muyembe-Tamfum, J.-J.
AU - Nason, M.C.
AU - Smith, P.G.
AU - Wang, R.
AU - Henao-Restrepo, A.M.
AU - De Gruttola, V.
PY - 2020/4/2
Y1 - 2020/4/2
N2 - As in the ongoing Covid-19 pandemic, global outbreaks of infectious illnesses often develop quickly and resolve in unpredictable ways. In this report, strategies to develop high-quality evidence to guide the development of new therapies are proposed.
AB - As in the ongoing Covid-19 pandemic, global outbreaks of infectious illnesses often develop quickly and resolve in unpredictable ways. In this report, strategies to develop high-quality evidence to guide the development of new therapies are proposed.
U2 - 10.1056/NEJMsb1905390
DO - 10.1056/NEJMsb1905390
M3 - Editorial
VL - 382
SP - 1366
EP - 1369
JO - New England Journal of Medicine
JF - New England Journal of Medicine
SN - 0028-4793
IS - 14
ER -
